Synthesis of novel 1α,25-dihydroxy-19-norvitamin D3 with an amide conjugate

Heterocycles

Volumn 62, Issue , 2004, Pages 423-436

  Suhara, Yoshitomo ^a,b   Ono, Keiichiro ^a   Yoshida, Akihiro ^a,c   Fujishima, Toshie ^a   Saito, Nozomi ^a   Honzawa, Shinobu ^a   Kishimoto, Seishi ^a   Sugiura, Takayuki ^a   Waku, Keizo ^a   Takayama, Hiroaki ^a   Kittaka, Atsushi ^a  

^a TEIKYO UNIVERSITY   (Japan)

^b KOBE PHARMACEUTICAL UNIVERSITY   (Japan)

^c JAPAN CHEMICAL INNOVATION INSTITUTE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

1ALPHA,25 DIHYDROXY 19 NORVITAMIN D3; 2 (3 HYDROXYPROPOXY) 6 OXO 5 AZA 9,10 SECO 19 NORCHOLEST 7 ENE 1,3,25 TRIOL; 6 OXO 5 AZA 9,10 SECO 19 NORCHOLEST 7 ENE 1,3,25 TRIOL; 6 OXO 9,10 SECO 19 NORCHOLEST 7 ENE 1,2,3,25 TETRAOL; AMIDE; COLECALCIFEROL DERIVATIVE; UNCLASSIFIED DRUG; VITAMIN D RECEPTOR;

ARTICLE; BINDING AFFINITY; CATTLE; CELL DIFFERENTIATION; CHEMICAL BOND; CONJUGATE; DRUG BINDING SITE; DRUG POTENCY; DRUG SYNTHESIS; HUMAN; HUMAN CELL; LIGAND BINDING; STRUCTURE ACTIVITY RELATION;

EID: 0345828928     PISSN: 03855414     EISSN: None     Source Type: Journal    
DOI: 10.3987/com-03-s(p)34     Document Type: Article

References (45)

1. 'Vitamin D', ed. by D. Feldman, F. H. Glorieux, and J. W. Pike, Academic Press, New York, 1997.
2. R. Bouillon, W. H. Okamura, and A. W. Norman, Endocr. Rev., 1995, 16, 200.
3. (a) K. L. Perlman, R. R. Sicinski, H. K. Schnoes, and H. F. DeLuca, Tetrahedron Lett., 1990, 31, 1823;
4. (b) K. L. Perlman, R. E. Swenson, H. E. Paaren, H. K. Schnoes, and H. F. DeLuca, Tetrahedron Lett., 1991, 32, 7663;
5. (c) R. R. Sicinski, K. L. Perlman, and H. F. DeLuca, J. Med. Chem., 1994, 37, 3730;
6. (d) R. R. Sicinski, J. M. Prahl, C. M. Smith, and H. F. DeLuca, J. Med. Chem., 1998, 41, 4662;
7. (e) R. R. Sicinski, P. Rotkiewicz, A. Kolinski, W. Sicinska, J. M. Prahl, C. M. Smith, and H. F. DeLuca, J. Med. Chem., 2002, 45, 3366;
8. (f) P.-Q. Huang, K. Sabbe, M. Pottie, and M. Vandewalle, Tetrahedron Lett., 1995, 36, 8299;
9. (g) H. Hilpert and B. Wirz, Tetrahedron, 2001, 57, 681;
10. (h) T. Hanazawa, H. Inamori, T. Masuda, S. Okamoto, and F. Sato, Org. Lett., 2001, 3, 2205;
11. (i) Y. Wu, Y. Zhao, H. Tian, P. De Clercq, M. Vandewalle, M. Berthier, G. Pellegrino, P. Maillos, and J.-C. Pascal, Eur. J. Org. Chem., 2001, 3779;
12. (j) T. Okano, K. Nakagawa, N. Kubodera, K. Ozono, A. Isaka, A. Osawa, M. Terada, and K. Mikami, Chem. Biol., 2000, 7, 173;
13. (k) K. Mikami, A. Osawa, A. Isaka, M. Terada, and T. Okano, Tetrahedron Lett., 1998, 39, 3359;
14. (l) K. Mikami, Y. Koizumi, A. Osawa, M. Terada, H. Takayama, K. Nakagawa, and T. Okano, Synlett, 1999, 1899;
15. (m) M. Shimizu, Y. Iwasaki, Y. Shibamoto, M. Sato, H. F. DeLuca, and S. Yamada, Bioorg. Med. Chem. Lett., 2003, 13, 809.
16. (a) A. Yoshida, K. Ono, Y. Suhara, N. Saito, H. Takayama, and A. Kittaka, Synlett, 2003, 1175.
17. (b) K. Ono, A. Yoshida, N. Saito, T. Fujishima, S. Honzawa, Y. Suhara, S. Kishimoto, T. Sugiura, K. Waku, H. Takayama, and A. Kittaka, J. Org. Chem., 2003, 68, in press.
18. Singlet oxygen adducts to the trine system in 1: (a) S. Yamada, K. Yamamoto, H. Naito, T. Suzuki, M. Ohmori, H. Takayama, Y. Shiina, C. Miyaura, H. Tanaka, E. Abe, T. Suda, I. Matsunaga, and Y. Nishii, J. Med. Chem., 1985, 28, 1148;
19. (b) Y. Shiina, C. Miyaura, H. Tanaka, E. Abe, S. Yamada, K. Yamamoto, E. Ino, H. Takayama, I. Matsunaga, Y. Nishii, and T. Suda, J. Med. Chem., 1985, 28, 1153.
20. (a) For 2-methyl series: K. Konno, S. Maki, T. Fujishima, Z. Liu, D. Miura, M. Chokki, and H. Takayama, Bioorg. Med. Chem. Lett., 1998, 8, 151;
21. (b) K. Konno, T. Fujishima, S. Maki, Z. Liu, D. Miura, M. Chokki, S. Ishizuka, K. Yamaguchi, Y. Kan, M. Kurihara, N. Miyata, C. Smith, H. F. DeLuca, and H. Takayama, J. Med. Chem., 2000, 43, 4247.
22. For 2α-alkyl and 2α-(ω-hydroxyalkyl) series: (a) Y. Suhara, K. Nihei, H. Tanigawa, T. Fujishima, K. Konno, K. Nakagawa, T. Okano, and H. Takayama, Bioorg. Med. Chem. Lett., 2000, 10, 1129;
23. (b) Y. Suhara, K. Nihei, M. Kurihara, A. Kittaka, K. Yamaguchi, T. Fujishima, K. Konno, N. Miyata, and H. Takayama, J. Org. Chem., 2001, 66, 8760;
24. (c) S. Honzawa, Y. Suhara, K. Nihei, N. Saito, S. Kishimoto, T. Fujishima, M. Kurihara, T. Sugiura, K. Waku, H. Takayama, and A. Kittaka, Bioorg. Med. Chem. Lett., 2003, 13, in press.
25. A. Kittaka, Y. Suhara, H. Takayanagi, T. Fujishima, M. Kurihara, and H. Takayama, Org. Lett., 2000, 2, 2619.
26. H. Takayama, A. Kittaka, T. Fujishima, and Y. Suhara, 'Vitamin D Analogs in Cancer Prevention and Therapy, Recent Results in Cancer Research 164,' ed. by J. Reichrath, M. Friedrich, and W. Tilgen, Springer-Verlag, Berlin Heidelberg, 2003, pp. 289-317.
27. Y. Suhara, A. Kittaka, S. Kishimoto, M. J. Calverley, T. Fujishima, N. Saito, T. Sugiura, K. Waku, and H. Takayama, Bioorg. Med. Chem. Lett., 2002, 12, 3255.
28. A. Kittaka, M. Kurihara, S. Peleg, Y. Suhara, and H. Takayama, Chem. Pharm. Bull., 2003, 51, 357.
29. (a) K. Miyamoto, E. Murayama, K. Ochi, H. Watanabe, and N. Kubodera, Chem. Pharm. Bull., 1993, 41, 1111;
30. (b) N. Tsugawa, K. Nakagawa, M. Kurobe, Y. Ono, N. Kubodera, K. Ozono, and T. Okano, Biol. Pharm. Bull., 2000, 23, 66.
31. A part of this study has been published as a communication: Y. Suhara, A. Kittaka, K. Ono, M. Kurihara, T. Fujishima, A. Yoshida, and H. Takayama, Bioorg. Med. Chem. Lett., 2002, 12, 3533.
32. Molecular modeling study on compound (3a) docking in the ligand binding domain of the VDR was reported in ref. 13.
33. (a) K. R. Muralidharan, A. R. de Lera, S. D. Isaeff, A. W. Norman, and W. H. Okamura, J. Org. Chem., 1993, 58, 1895.
34. (b) A. W. Norman, R. Bouillon, M. C. Farach-Carson, J. E. Bishop, L.-X. Zhou, L. Nemere, J. Zhao, K. R. Muralidharan, and W. H. Okamura, J. Biol. Chem., 1993, 268, 20022.
35. (c) T. Fujishima, K. Konno, K. Nakagawa, M. Kurobe, T. Okano, and H. Takayama, Bioorg. Med. Chem., 2000, 8, 123.
36. Y. Ichikawa, Y. Igarashi, M. Ichikawa, and Y. Suhara, J. Am. Chem. Soc., 1998, 120, 3007.
37. J. Kiegiel, P. M. Wovkulich, and M. R. Uskokovic, Tetrahedron Lett., 1991, 32, 6057.
38. B. M. Trost, J. Dumas, and M. Villa, J. Am. Chem. Soc., 1992, 114, 9836.
39. S. T. Anisfeld and P. Lansbury, Jr., J. Org. Chem., 1990, 55, 5560.
40. Y. Imae, A. Manaka, N. Yoshida, Y. Ishimi, T. Shinki, E. Abe, T. Suda, K. Konno, H. Takayama, and S. Yamada, Biochim. Biophys. Acta, 1994, 1213, 302.
41. 3 (2) for the porcine VDR was reported as 30% of the natural hormone 1, see: X. Zhou, G.-D. Zhu, D. Van Haver, M. Vandewalle, P. J. De Clercq, A. Verstuyf, and R. Bouillon, J. Med. Chem., 1999, 42, 3539. For the bovine thymus VDR, it was 17%, see: ref. 4b.
42. S. J. Collins, F. W. Ruscetti, R. E. Gallagher, and R. C. Gallo, J. Exp. Med., 1979, 149, 969.
43. (a) K. Umesono, K. K. Murakami, C. C. Thompson, and R. M. Evans, Cell, 1991, 65, 1255;
44. (b) R. M. Evans, Science, 1988, 240, 889.
45. T. Doi, I. Hijikuro, and T. Takahashi, J. Am. Chem. Soc., 2001, 123, 3716.